Furthermore, it also had an effect on the regulation of the genes involved in the miR-130a-5p/MBOAT2 pathway, including MBOAT2, FASN, SREBP1, FABP4, and PPARγ, suggesting that oral L. salivarius SNK-6 treatment could alleviate NAFLD. The gene discussed is FABP4; the disease is metabolic dysfunction-associated steatotic liver disease.